Literature DB >> 33649333

Unmasking the immune microecology of ductal carcinoma in situ with deep learning.

Priya Lakshmi Narayanan1,2, Shan E Ahmed Raza3,4, Allison H Hall5, Jeffrey R Marks6, Lorraine King6, Robert B West7, Lucia Hernandez8, Naomi Guppy9,10, Mitch Dowsett11,12, Barry Gusterson3, Carlo Maley13, E Shelley Hwang6, Yinyin Yuan14,15.   

Abstract

Despite increasing evidence supporting the clinical relevance of tumour infiltrating lymphocytes (TILs) in invasive breast cancer, TIL spatial variability within ductal carcinoma in situ (DCIS) samples and its association with progression are not well understood. To characterise tissue spatial architecture and the microenvironment of DCIS, we designed and validated a new deep learning pipeline, UNMaSk. Following automated detection of individual DCIS ducts using a new method IM-Net, we applied spatial tessellation to create virtual boundaries for each duct. To study local TIL infiltration for each duct, DRDIN was developed for mapping the distribution of TILs. In a dataset comprising grade 2-3 pure DCIS and DCIS adjacent to invasive cancer (adjacent DCIS), we found that pure DCIS cases had more TILs compared to adjacent DCIS. However, the colocalisation of TILs with DCIS ducts was significantly lower in pure DCIS compared to adjacent DCIS, which may suggest a more inflamed tissue ecology local to DCIS ducts in adjacent DCIS cases. Our study demonstrates that technological developments in deep convolutional neural networks and digital pathology can enable an automated morphological and microenvironmental analysis of DCIS, providing a new way to study differential immune ecology for individual ducts and identify new markers of progression.

Entities:  

Year:  2021        PMID: 33649333      PMCID: PMC7921670          DOI: 10.1038/s41523-020-00205-5

Source DB:  PubMed          Journal:  NPJ Breast Cancer        ISSN: 2374-4677


  31 in total

1.  Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.

Authors:  Carlos R Gil Del Alcazar; Sung Jin Huh; Muhammad B Ekram; Anne Trinh; Lin L Liu; Francisco Beca; Xiaoyuan Zi; Minsuk Kwak; Helga Bergholtz; Ying Su; Lina Ding; Hege G Russnes; Andrea L Richardson; Kirsten Babski; Elizabeth Min Hui Kim; Charles H McDonnell; Jon Wagner; Ron Rowberry; Gordon J Freeman; Deborah Dillon; Therese Sorlie; Lisa M Coussens; Judy E Garber; Rong Fan; Kristie Bobolis; D Craig Allred; Joon Jeong; So Yeon Park; Franziska Michor; Kornelia Polyak
Journal:  Cancer Discov       Date:  2017-06-26       Impact factor: 39.397

Review 2.  Spatial Heterogeneity in the Tumor Microenvironment.

Authors:  Yinyin Yuan
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

3.  Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.

Authors:  Andreas Heindl; Ivana Sestak; Kalnisha Naidoo; Jack Cuzick; Mitchell Dowsett; Yinyin Yuan
Journal:  J Natl Cancer Inst       Date:  2018-02-01       Impact factor: 13.506

Review 4.  Ductal carcinoma in situ, complexities and challenges.

Authors:  Gregory D Leonard; Sandra M Swain
Journal:  J Natl Cancer Inst       Date:  2004-06-16       Impact factor: 13.506

5.  Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.

Authors:  Fresia Pareja; David N Brown; Ju Youn Lee; Arnaud Da Cruz Paula; Pier Selenica; Rui Bi; Felipe C Geyer; Andrea Gazzo; Edaise M da Silva; Mahsa Vahdatinia; Anthe A Stylianou; Lorenzo Ferrando; Hannah Y Wen; James B Hicks; Britta Weigelt; Jorge S Reis-Filho
Journal:  Clin Cancer Res       Date:  2020-03-27       Impact factor: 12.531

6.  Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.

Authors:  Lucia Hernandez; Paul M Wilkerson; Maryou B Lambros; Adriana Campion-Flora; Daniel Nava Rodrigues; Arnaud Gauthier; Cecilia Cabral; Vidya Pawar; Alan Mackay; Roger A'Hern; Caterina Marchiò; Jose Palacios; Rachael Natrajan; Britta Weigelt; Jorge S Reis-Filho
Journal:  J Pathol       Date:  2012-03-21       Impact factor: 7.996

7.  OpenSlide: A vendor-neutral software foundation for digital pathology.

Authors:  Adam Goode; Benjamin Gilbert; Jan Harkes; Drazen Jukic; Mahadev Satyanarayanan
Journal:  J Pathol Inform       Date:  2013-09-27

8.  Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent.

Authors:  Angel Cruz-Roa; Hannah Gilmore; Ajay Basavanhally; Michael Feldman; Shridar Ganesan; Natalie N C Shih; John Tomaszewski; Fabio A González; Anant Madabhushi
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

Review 9.  Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.

Authors:  Kylie L Gorringe; Stephen B Fox
Journal:  Front Oncol       Date:  2017-10-23       Impact factor: 6.244

Review 10.  Classifying the evolutionary and ecological features of neoplasms.

Authors:  Carlo C Maley; Athena Aktipis; Trevor A Graham; Andrea Sottoriva; Amy M Boddy; Michalina Janiszewska; Ariosto S Silva; Marco Gerlinger; Yinyin Yuan; Kenneth J Pienta; Karen S Anderson; Robert Gatenby; Charles Swanton; David Posada; Chung-I Wu; Joshua D Schiffman; E Shelley Hwang; Kornelia Polyak; Alexander R A Anderson; Joel S Brown; Mel Greaves; Darryl Shibata
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

View more
  7 in total

Review 1.  Ductal Carcinoma in Situ: State-of-the-Art Review.

Authors:  Lars J Grimm; Habib Rahbar; Monica Abdelmalak; Allison H Hall; Marc D Ryser
Journal:  Radiology       Date:  2021-12-21       Impact factor: 11.105

2.  Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I-III colorectal cancer.

Authors:  Yanqi Huang; Lan He; Zhenhui Li; Xin Chen; Chu Han; Ke Zhao; Yuan Zhang; Jinrong Qu; Yun Mao; Changhong Liang; Zaiyi Liu
Journal:  Chin J Cancer Res       Date:  2022-02-28       Impact factor: 5.087

Review 3.  Learning to distinguish progressive and non-progressive ductal carcinoma in situ.

Authors:  Anna K Casasent; Mathilde M Almekinders; Charlotta Mulder; Proteeti Bhattacharjee; Deborah Collyar; Alastair M Thompson; Jos Jonkers; Esther H Lips; Jacco van Rheenen; E Shelley Hwang; Serena Nik-Zainal; Nicholas E Navin; Jelle Wesseling
Journal:  Nat Rev Cancer       Date:  2022-10-19       Impact factor: 69.800

Review 4.  A Study of the Recent Trends of Immunology: Key Challenges, Domains, Applications, Datasets, and Future Directions.

Authors:  Sharnil Pandya; Aanchal Thakur; Santosh Saxena; Nandita Jassal; Chirag Patel; Kirit Modi; Pooja Shah; Rahul Joshi; Sudhanshu Gonge; Kalyani Kadam; Prachi Kadam
Journal:  Sensors (Basel)       Date:  2021-11-23       Impact factor: 3.576

5.  Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ.

Authors:  Faranak Sobhani; Sathya Muralidhar; Azam Hamidinekoo; Allison H Hall; Lorraine M King; Jeffrey R Marks; Carlo Maley; Hugo M Horlings; E Shelley Hwang; Yinyin Yuan
Journal:  NPJ Breast Cancer       Date:  2022-09-15

6.  Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.

Authors:  Mathilde M Almekinders; Tycho Bismeijer; Tapsi Kumar; Fei Yang; Bram Thijssen; Rianne van der Linden; Charlotte van Rooijen; Shiva Vonk; Baohua Sun; Edwin R Parra Cuentas; Ignacio I Wistuba; Savitri Krishnamurthy; Lindy L Visser; Iris M Seignette; Ingrid Hofland; Joyce Sanders; Annegien Broeks; Jason K Love; Brian Menegaz; Lodewyk Wessels; Alastair M Thompson; Karin E de Visser; Erik Hooijberg; Esther Lips; Andrew Futreal; Jelle Wesseling
Journal:  Br J Cancer       Date:  2022-06-29       Impact factor: 9.075

Review 7.  Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology.

Authors:  Faranak Sobhani; Ruth Robinson; Azam Hamidinekoo; Ioannis Roxanis; Navita Somaiah; Yinyin Yuan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-02-06       Impact factor: 11.414

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.